Sciensano collects data on rotavirus infections in order to follow the trends of this disease and its impact on public health in the Belgian population. Sciensano’s Belgian Official Medicines Control Laboratory (OMCL) is responsible, in cooperation with the European OMCL network, for quality control of the vaccine against rotavirus before it is put on the market.
